Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Birnbaum

Showing results (281-290 of 301) with videos related to

Pageof 31
Sort By:
Cancer Research|May 20, 2016
Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem-like CellsJulie Giraud, Laura M Failla, Jean-Marc Pascussi, et al.
Cells|September 23, 2022
MARCKS as a Potential Therapeutic Target in Inflammatory Breast CancerMaroua Manai, Ines ELBini-Dhouib, Pascal Finetti, et al.
Molecular Cancer Research : MCR|December 29, 2005
Comprehensive profiling of 8p11-12 amplification in breast cancerVéronique Gelsi-Boyer, Béatrice Orsetti, Nathalie Cervera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Stem Cell Reports|February 11, 2014
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterpartsSuling Liu, Yang Cong, Dong Wang, et al.
Blood|August 12, 2009
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, et al.
Oncotarget|October 22, 2016
Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective studyAnthony Gonçalves, François Bertucci, Arnaud Guille, et al.
Nature|July 17, 2019
Author Correction: Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Nature|May 24, 2019
Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Blood|February 21, 2012
Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromesFrederik Damm, Olivier Kosmider, Véronique Gelsi-Boyer, et al.
Pageof 31

Showing results (281-290 of 301) with videos related to

Sort By:
Pageof 31
Cancer Research|May 20, 2016
Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem-like CellsJulie Giraud, Laura M Failla, Jean-Marc Pascussi, et al.
Cells|September 23, 2022
MARCKS as a Potential Therapeutic Target in Inflammatory Breast CancerMaroua Manai, Ines ELBini-Dhouib, Pascal Finetti, et al.
Molecular Cancer Research : MCR|December 29, 2005
Comprehensive profiling of 8p11-12 amplification in breast cancerVéronique Gelsi-Boyer, Béatrice Orsetti, Nathalie Cervera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Stem Cell Reports|February 11, 2014
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterpartsSuling Liu, Yang Cong, Dong Wang, et al.
Blood|August 12, 2009
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, et al.
Oncotarget|October 22, 2016
Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective studyAnthony Gonçalves, François Bertucci, Arnaud Guille, et al.
Nature|July 17, 2019
Author Correction: Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Nature|May 24, 2019
Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Blood|February 21, 2012
Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromesFrederik Damm, Olivier Kosmider, Véronique Gelsi-Boyer, et al.
Pageof 31